Revance Therapeutics | Kewajiban Lancar

Current Liabilities Perubahan Tanggal
ALKERMES USD 503.11M 15.92M 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Pacira USD 97.38M 3.72M 2023-12
Supernus Pharmaceuticals USD 290.2M 2.66M 2023-12



Revance Therapeutics Kewajiban Lancar - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Apr 2024.